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In recent years there have appeared occasional reports of cases
of hypothyroidism in which associated findings have been inter-
preted as evidence of the presence of myxedema heart disease.
Fahr5 has pointed out the lack of consideration which has been
given to the cardiac features of hypothyroidism in text-books, and
until the recent publication of a volume12 devoted to heart disease
the space given to this subject was limited. There is no doubt that
an advanced grade of hypothyroidism is an uncommon condition
and, furthermore, that a striking degree of myxedema heart disease
is rare, however, the dangers attendant upon its improper manage-
ment, and its response to careful therapy make its consideration a
matter of importance.
Following the reports of a small number of cases by Zondek"4,
by Assman1 and by Meissner9, Fahr' reported six cases which he
considered typical of myxedema heart disease. One of his cases
was relieved of congestive failure by thyroid extract therapy after
rest and digitalis had failed. Other clinicians have been sceptical
of the existence of this clinical entity. Willius and Haines"3
reviewed 162 cases of hypothyroidism and were unable to find any
instance of cardiovascular disease which they could definitely attrib-
ute to myxedema, but only a few of these cases were carefully
studied for changes in the cardiac diameters and in the electro-
cardiagram both before and after thyroid extract therapy. Chris-
tian3 reviewed 32 cases and failed to find any with cardiac findings
similar to those described by Fahr6, but he emphasized the import-
ance of cautious thyroid extract therapy where cardiac disease might
be present. More recently, reports of cases of myxedema heart
disease which have been carefully studied have been published by
Means, White and Krantz8, Holtzman7, Davis4, Tung"1 and others,
and furnish convincing evidence that the cardiovascular system must
not be overlooked in planning the treatment of myxedema. Ayman,
Rosenblum and Falcon-Lesses2 have reported two cases of myxe-
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dema heart disease and have also carefully reviewed the 22 cases
in the recent literature.
For the diagnosis of myxedema heart disease the criteria which
were emphasized by Zondek"4 were an enlargement of the heart
with a feeble heart action, low amplitude P and T waves in the
electrocardiagram, and a decrease in the heart size and an increase
in the voltage of the electrocardiagraphic complexes following
thyroid extract therapy. Thacher and White10 have reported the
electrocardiagraphic changes associated with myxedema. There is
absence or inversion of the T waves in Lead II and the P and QRS
complexes are usually of low amplitude. The absence or inversion
of the T waves in all leads has also been commented upon, and
Fahr6 has placed emphasis upon the changes in the T wave in
Lead I. In three of the cases reported by Fahr evidence of left
ventricular preponderance disappeared after thyroid extract therapy.
Since these electrocardiagraphic changes are not limited to cases
with associated heart disease and are only corroborative evidence
of the presence of that condition, the demonstration of cardiac
enlargement would seem essential for diagnosis. In the 22 cases
reviewed by Ayman and his collaborators2 an average decrease of
3.3 cm. in cardiac diameter was found following thyroid extract
therapy, a minimum decrease of 1.0 cm. and a maximum of 6.3 cm.
Means, White and Krantz8 suggest that a lowered tonus of the
cardiac muscle may be the cause of the dilatation which disappears
after thyroid extract has been given. Although cardiac failure due
to myxedema heart disease has been reported, it is certainly not a
common finding, and the symptoms and signs of cardiac failure may
often be lacking because of the low level of the patient's activity
and their absence cannot be relied upon as evidence to exclude heart
disease. Two factors which often accompany myxedema and which
may affect the size of the heart are obesity and anemia and in con-
sidering the decrease in the size of the heart following thyroid
extract therapy it is always necessary to keep in mind the possibility
that the decrease may have accompanied an improvement in the
red blood cell count or a decrease in weight. In summary, the
criteria for the diagnosis of myxedema heart disease may be tenta-
tively considered as follows: (1) the presence of hypothyroidism,
(2) cardiac enlargement, (3) low amplitude electrocardiagraphic
complexes which attain greater voltage following thyroid extract
therapy, (4) a decrease in cardiac area following thyroid extract
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therapy which cannot be ascribed wholly to weight loss or improve-
ment in red blood count, (5) absence of evidence of hypertensive,
valvular or coronary heart disease.
Myxedema and arteriosclerosis are frequently associated, and
coronary sclerosis may also be present. It is the presence of arterio-
sclerosis and the possibility of coronary sclerosis which makes the
management of these patients a matter of great importance, and it
is only logical to institute thyroid extract therapy with care, and to
ascertain whether or not cardiac dilatation is present before begin-
ning treatment. Christian3 and White"2 have emphasized the neces-
sity of raising the basal metabolic rate slowly when dilatation or
angina pectoris is present in order to avoid suddenly throwing an
extra load on the cardiovascular system. The initial dose of thyroid
extract given to patients who show evidence of heart disease should
be small. It is well to keep these patients in bed during the first
few days of the treatment and to start with a dose of one grain
daily, which may be gradually increased if the patient does not
respond to that amount.
The following case report will serve to illustrate the criteria
for the diagnosis of myxedema heart disease and the changes which
occur during a course of therapy. It will be seen that marked
improvement was obtained with only small doses of thyroid extract.
J. McD. a white carpenter, aged 57, was admitted to the hospital on
February 10, 1932. He claimed to have been in good health until August,
1929, when he suffered injuries to his right ankle and right hand which
required care for about two months. Since January, 1930, there had been
a gradual development of lethargy, dryness of the skin, susceptibility to cold
and deepness of voice. Because of an impairment of his general sense of
well-being and lack of ambition he did not return to work; although prior
to the onset of his symptoms he had always enjoyed his occupation. At no
time had the patient noticed either dyspnea or precordial pain and there
was no history of attacks of substernal oppression, but of course his activity
had been restricted. The past history and the family history were irrelevant.
On physical examination the outstanding feature was the man's appear-
ance: the stolid, expressionless, puffy face, the slow thick speech and the
slowness of his movements were striking. The tongue was swollen, there
were supraclavicular pads, and the skin was cracked, scaly and dry. The
hair on the scalp and at the eyebrows was scanty. The heart was greatly
enlarged, and the sounds were of poor quality. The blood-pressure was
120/90; the pulse 84. There was a secondary anemia. The initial basal
metabolism rate was minus 57 per cent. The orthodiascope showed a
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marked cardiac enlargement with sluggish movement of the borders; and
the electrocardiagram showed left axis deviation with all the complexes of
low amplitude and the T waves either diphasic or negative in all leads.
A
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FIGURE III. These reductions of orthodiascopic tracings of
the cardiac shadow illustrate the marked changes in the cardiac
diameters following thyroid extract therapy. The movements of
the heart borders on February 11, (A) were very sluggish, while
those observed on April 2 (B) were of normal excursion.
In Table I certain data concerning the patient's course are recorded.
Figure I shows electrocardiagrams taken before and Figure II after thyroid
extract therapy was begun, and Figure III presents reductions of orthodia-
scopic tracings of the car.diac diameters.
TABLE I
Date Feb. 11 Feb. 22 Mar. 9 Apr. 2
Weight (lbs.) ....................... 158 154Y4 148%4 138
Red Blood Cell Count .................. 2,700,000 3,300,000 3,700,000
Basal Met. Rate.......................57% -3 87o -8%
Trans. Diam. of Chest .............. 27.2 - 26.9
Trans. Diam. Heart (cm.) ........ 16.3 13.5
Cardio-Thoracic Ratio ................ .60 .50
Cardiac Area (sq. cm.) ................ 134 105
Thyroid Ext. (gr.) daily ............ 1.0 1.5 1.0
The case which has been reported has been shown to have a
history, physical findings and basal metabolic rate typical of
myxedema. The electrocardiagraphic tracing, showing the com-
plexes of low amplitude, is similar to those usually found in this
condition. An orthodiascopic examination of the patient's heart
before thyroid extract was given showed marked cardiac enlarge-
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ment and feeble cardiac action. An improvement in all the findings
except those observed orthodiascopically might be expected in any
case of myxedema following thyroid extract therapy, but it is felt
that the decrease in cardiac diameters observed in this case is evi-
dence that myxedema heart disease was present. There was an
improvement in the anemia in this case and also a loss of weight,
but it is felt that the change in cardiac size is more logically related
to decrease in the degree of dilatation of myxedema heart disease
present than to either of those factors. It is presumed that the low
level of activity of the patient accounts for the absence of symptoms
referable to the cardiovascular system.
This case report is given in an effort to illustrate the criteria
for the diagnosis of this condition and the desirability of obtaining
teleroentgenographic studies before beginning thyroid extract
therapy. While it is recognized that the acceptance of myxedema
heart disease as a clinical entity may not be felt justifiable by all
clinicians, the importance of recognizing certain not uncommon
cardiovascular changes associated with myxedema is apparent.
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